Press Releases

Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results SUNNYVALE, Calif., August 17, 2016 – Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2016. Read More »
Accuray CE Marks its New Radixact™ System

Next Generation Image-Guided Radiation Therapy Platform and Integrated Software Solutions are Now Available for Use by Clinicians in the European Union

Read More »
New Data Demonstrating TomoTherapy® System Adaptive Capabilities and Workhorse Reliability Presented at Leading Scientific Meeting for Medical Physicists SUNNYVALE, Calif., August 4, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that new studies demonstrating the TomoTherapy® System’s leading-edge adaptive therapy capabilities and value as a mainstream radiation therapy device were presented at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Washington, DC, July 31 – August 4, 2016. More than 35 studies evaluating the system were shared during poster and oral presentations. The TomoTherapy System is used worldwide to treat a wide range of cancer cases, from the routine to complex, with extreme precision. Read More »
New Data Show InCise™ Multileaf Collimator for the CyberKnife® M6™ System may Expand Patient Population Eligible for Precise Radiation Treatments SUNNYVALE, Calif., August 4, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that more than 45 studies on the use of the CyberKnife® System were presented during poster and oral sessions at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Washington, DC, July 31 – August 4, 2016. The CyberKnife System is the only stereotactic body radiation therapy (SBRT) system capable of tracking and automatically correcting for target motion in real time, even while the tumor moves. The System's sub-millimeter accuracy enables clinicians to effectively treat tumors while preserving healthy tissue. Read More »
Accuray Retires Remaining 3.75% Convertible Debt SUNNYVALE, Calif., August 2, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today the Company has settled the remaining principal amount and accrued interest thereon of the 3.75% Convertible Senior Notes (the “2016 Notes”). The 2016 Notes were settled on August 1, 2016 for cash of $37.3 million, which included $36.6 million in principal and $0.7 million in accrued interest. Read More »
TomoTherapy® System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy in Low-Risk Breast Cancer Patients SUNNYVALE, Calif., July 21, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today preliminary results from a prospective, phase II trial evaluating once-daily accelerated partial breast irradiation (APBI) in patients treated with the TomoTherapy® System. The study, published in the June issue of the peer-reviewed AntiCancer Research, International Journal of Cancer Research and Treatment, reported no recurrence of cancer in the treated breast at median follow-up of 34 months. Additionally, more than 95 percent of patients and their physicians rated cosmesis -- preservation of the normal appearance of the breast -- as good/excellent. Read More »
Accuray Products Continue to Receive Highest Composite User Satisfaction Ratings in Latest MD Buyline Report SUNNYVALE, Calif., July 14, 2016 – Accuray Incorporated (NASDAQ: ARAY) announced today that its CyberKnife® and TomoTherapy® Systems continue to set the standard for overall user satisfaction. The Accuray systems received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q2 2016 MD Buyline Market Intelligence Briefing™. The most recent ratings trend also shows Accuray has achieved the highest ratings among industry peers over the past three years. Read More »
Accuray to Report Fiscal 2016 Fourth Quarter And Full Year Results On August 17, 2016 SUNNYVALE, CALIF., July 7, 2016—Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal fourth quarter and full year ended June 30, 2016 on Wednesday, August 17, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day. Read More »